surmount-2 tirzepatide type 2 diabetes weight loss results 2023 2024 Was Associated with Improved Health-Related Quality of Life in Adults with Obesity or Overweight and Diabetes: from the Phase 3 Trial | Therapy 🔴Tirzepatide for obesity and diabetes

For those primarily focused on improving glycemic control, Ozempic is a valuable tool in lowering blood sugar levels and providing the added benefit of weight reduction

Incorporating strength training protocols 2-3 times weekly preserves muscle and improves transformation quality

Pharmacy benefit managers (PBMs), like CVS Caremark, are constantly evaluating drugs based on their clinical effectiveness, pricing, and rebates

SURMOUNT-1 results by dose The landmark SURMOUNT-1 trial enrolled 2,539 adults with obesity or overweight (BMI of 30 or higher, or 27 or higher with at least one weight-related complication)

So the question matters: do tirzepatide results hold up outside the trial setting